Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report

Intravenous bisphosphonates are widely used in the management of solid tumors, metastatic bone disease, metabolic bone diseases and hypercalcemia of malignancies. Recently, yearly intravenous injections of zoledronic acid, one of the potent nitrogen-containing bisphosphonates, have also been approve...

Full description

Bibliographic Details
Main Author:	Abdulmohsen H. Al Elq
Format:	Article
Language:	English
Published:	Oman Medical Specialty Board 2013-03-01
Series:	Oman Medical Journal
Subjects:	Bisphosphonates Zoledronic acid Adverse effects Hypocalcemia.
Online Access:	http://www.omjournal.org/fultext_PDF.aspx?DetailsID=367&type=fultext

Similar Items

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

The anti-tumour effects of zoledronic acid
by: Jamal Zekri, et al.
Published: (2014-03-01)

Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01)

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
by: Ayoub Charehbili, et al.
Published: (2013-10-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
by: Räkel A, et al.
Published: (2011-03-01)

Response to zoledronic acid in patients with active Paget's disease of bone: A retrospective study
by: Harsh Durgia, et al.
Published: (2019-01-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

SUBTROCHANTERIC FRACTURE IN A PATIENT RECEIVING ZOLEDRONIC ACID THERAPY FOR METASTATIC BREAST CANCER
by: Ishiguro, Naoki, et al.
Published: (2011)

Effects of zoledronic acid on osteoblasts in three-dimensional culture
by: Flora Thibaut, et al.
Published: (2015-03-01)

Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats
by: Belfrage Ola, et al.
Published: (2012-12-01)

Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
by: Fatemeh Rostami-Golmohammadi, et al.
Published: (2015-02-01)

Collapsing Focal Segmental Glomerulosclerosis Resulting from a Single Dose of Zoledronate
by: Javier A. Neyra, et al.
Published: (2014-10-01)

Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy
by: Sanjay Kumar Bhadada, et al.
Published: (2019-11-01)

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
by: Fateme Rostami Golmohamdi, et al.
Published: (2016-12-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
by: Paul K Piper Jr, et al.
Published: (2009-06-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Response to Zoledronic Acid Infusion in Children With Fibrous Dysplasia
by: Sujit Kumar Tripathy, et al.
Published: (2020-11-01)

Effect of Zoledronic Acid on Maxillary Alveolar Bone Coverage in Rice Rats With and Without Dental Trauma
by: Callard, Jason Scott
Published: (2013)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
by: Lin H, et al.
Published: (2021-07-01)

Current Clinical Practice Scenario of Osteoporosis Management in India
by: Shailesh Jhaveri, et al.
Published: (2015-09-01)

Examining zoledronic acid for the prevention of bone loss in patients receiving bariatric surgery
by: Yi Liu, et al.
Published: (2021-06-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
by: Jun Xie, et al.
Published: (2019-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
by: Huang CF, et al.
Published: (2021-08-01)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer
by: Arif Awan, et al.
Published: (2021-02-01)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
by: Jarred Strickling, et al.
Published: (2019-04-01)

Comparative study of 99Tc-MDP and zoledronic acid in the treatment of osteoporosis
by: Ying Zhou, et al.
Published: (2020-08-01)

The Effect of Zoledronate Pretreatment on BMP Induced Bone Formation in Mice
by: Prichert, Marina
Published: (2011)

The Effect of Zoledronate Pretreatment on BMP Induced Bone Formation in Mice
by: Prichert, Marina
Published: (2011)

Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use
by: Abate, M., et al.
Published: (2022)

Zoledronic acid induced unilateral anterior uveitis
by: Shipra Gupta, et al.
Published: (2020-01-01)

The clinical characteristics, complications and treatment outcomes of patients with osteoporosis at Groote Schuur Hospital
by: Abdelfadiel, Omer Alawad Homaida
Published: (2021)

Evaluation of Patient Satisfaction, Preference and Side Effects after Annual Zoledronic Acid Infusion in Patients with Osteoporosis
by: Banu Dilek, et al.
Published: (2017-04-01)

Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo
by: Manuel Weber, et al.
Published: (2021-01-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

THE PROPHYLAXIS OF VERTEBRAL COMPRESSION REFRACTURES USING ZOLEDRONIC ACID
by: A. Yu. Kochish, et al.
Published: (2016-11-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
by: Wei Lin, et al.
Published: (2021-02-01)